Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Long-Term Debt Issuances
Ratios

Opus Genetics (IRD) Other Gross PP&E Adjustments (2021 - 2024)

Opus Genetics (IRD) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$237000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 47.2% to -$237000.0 in Q3 2023 year-over-year; TTM through Dec 2023 was -$6.0 million, a 3177.81% decrease, with the full-year FY2022 number at -$183000.0, down 210.17% from a year prior.
  • Other Gross PP&E Adjustments was -$237000.0 for Q3 2023 at Opus Genetics, down from -$116000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$59000.0 in Q4 2021 to a low of -$242000.0 in Q3 2021.
  • A 3-year average of -$156545.5 and a median of -$161000.0 in 2022 define the central range for Other Gross PP&E Adjustments.
  • Biggest YoY gain for Other Gross PP&E Adjustments was 46.26% in 2022; the steepest drop was 210.17% in 2022.
  • Opus Genetics' Other Gross PP&E Adjustments stood at -$59000.0 in 2021, then tumbled by 210.17% to -$183000.0 in 2022, then decreased by 29.51% to -$237000.0 in 2023.
  • Per Business Quant, the three most recent readings for IRD's Other Gross PP&E Adjustments are -$237000.0 (Q3 2023), -$116000.0 (Q2 2023), and -$197000.0 (Q1 2023).